Emergent BioSolutions announces presentation at J.P. Morgan conference; no material news disclosed

Emergent BioSolutions Inc.

Company to present at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024 at 9:00 a.m. PT.
Presenters: Interim CEO Haywood Miller and CFO Rich Lindahl.
Press release and slide deck furnished as exhibits; no financial results or guidance provided.
Filing is procedural; no material operational or financial updates.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.